All-In Summit: Gene therapy and a new era of medicine with Dr. Nicole Paulk

TL;DR

Dr. Nicole Paulk discusses the use of viruses as medicines through gene therapy, highlighting their potential to cure genetic disorders and treat cancer.

Transcript

next up is Nicole Paul I'm really excited for this talk I think you guys will find a lot of optimism in where technology is playing out in um in biology and bioengineering to cure fundamental human disease for nearly 20 years she's been developing Next Generation aav platforms for Gene repair Gene transfer and Gene editing and chief directed Evolut... Read More

Key Insights

• ⚕️ Gene therapy using viruses as medicine is a revolutionary and rapidly advancing field in modern medicine.
• 🔬 Viral gene therapy has historically been used to treat single gene genetic disorders, but now it has the potential to be used for a wide range of diseases.
• 🔎 Chemical medicines and protein medicines have been the previous eras of modern medicine, but now we are entering the era of "living medicines" using viruses, bacteria, and cells for targeted treatments.
• 🌐 Gene therapy has the potential to treat larger patient populations and multi-indications, such as cancer, by using universal gene therapies.
• 💊 Viral gene therapy has shown promising results in pre-clinical trials and animal studies, with the potential to cure diseases like inherited genetic blindness and brain cancer. ⏰ The regulatory process for viral gene therapies is time-consuming, and there are ethical considerations when it comes to non-disease-related treatments.
• 💰 Access to capital is a major hurdle for gene therapy companies due to the high costs associated with research, development, and manufacturing at scale.
• 🚀 The future of viral gene therapy includes possibilities like enhancing human potential, such as night vision, rejuvenation therapies, and altering the human body to withstand harsh environments.

Questions & Answers

Q: How does viral gene therapy work to treat genetic disorders?

Viral gene therapy involves using viruses to deliver functional copies of missing genes or correct mutations, allowing patients to have a normal, disease-free life.

Q: What are the potential applications of viral gene therapy beyond treating genetic disorders?

Viral gene therapy has the potential to enhance human potential by providing abilities like night vision or improving metabolism for harsh environments. It could also have applications in mental health and beauty enhancements.

Q: What are the main challenges in developing viral gene therapies?

The main challenges include access to capital, regulatory hurdles, and manufacturing at scale. The length of regulatory processes and the need for significant funding in the biotech industry can hinder the development and commercialization of these therapies.

Q: How does viral gene therapy differ from other forms of gene therapy?

Viral gene therapy uses viruses as vehicles to deliver genes, while other forms of gene therapy use different methods like nano-carriers or non-viral vectors. Viral gene therapy offers precise and efficient delivery, making it a promising approach for treating genetic disorders and cancer.

Q: What are the limitations of viral gene therapy in terms of gene size and payload?

Viral gene therapy using adeno-associated viruses (AAV) has a limited payload capacity of about 4.75 KB, which means it can only deliver genes that fit within that size. However, with gene editing techniques like CRISPR, the size limitation is not a constraint, allowing for potential treatment of all genetic diseases.

Answer: Viral gene therapy is a revolutionary field in biotechnology that holds great promise for curing genetic diseases and treating cancer. However, it faces challenges in terms of funding, regulations, and manufacturing scalability. With ongoing advancements in technology and continued research, viral gene therapy has the potential to transform modern medicine and improve human health.

Summary & Key Takeaways

• Viral gene therapy involves using viruses as medicines to treat genetic disorders by delivering functional copies of missing genes or correcting mutations.

• This form of gene therapy is revolutionary and represents a new era in modern medicine.

• Access to capital and regulatory hurdles are the main challenges in developing viral gene therapies, and manufacturing at scale is also a bottleneck.